人工骨の世界市場

人工骨の世界市場は2030年までに24億米ドルに達する

2024年に18億米ドルと推定される人工骨の世界市場は、2024年から2030年にかけてCAGR 5.7%で成長し、2030年には24億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるセラミックス材料は、CAGR 4.5%を記録し、分析期間終了時には8億3,570万米ドルに達する見込みです。複合材料セグメントの成長率は、分析期間でCAGR 7.2％と推定されます。

米国市場は4億6,100万米ドルと推定、中国はCAGR 5.6％で成長予測

米国の人工骨市場は、2024年に4億6,100万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに3億9,310万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは5.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.9%と5.1%と予測されています。欧州では、ドイツがCAGR 4.7%で成長すると予測されています。

世界の人工骨市場- 主要動向と促進要因のまとめ

人工骨が整形外科、外傷、再建外科の進歩に不可欠になっている理由とは？

人工骨は、損傷または欠損した骨組織を置換、修復、補強するために設計された合成または生物学的に設計された代用品です。整形外科、外傷治療、歯科再建、腫瘍学関連の骨欠損治療などにおいて、ますます不可欠なものとなっています。人口の高齢化、衝撃の大きい怪我、骨粗鬆症や変形性関節症などの慢性疾患により、骨に関連する疾患の世界の発生率が上昇するにつれ、信頼性の高い生体適合性のある骨補填材に対する需要は急増し続けています。

外傷や整形外科的処置において、人工骨は、骨再生を促進し、構造的空隙を埋め、生体力学的完全性を回復するための足場として機能します。これらの代用品は、脊椎固定術、長骨骨折の修復、関節再建術、複雑な再手術など、天然の骨移植では不十分あるいは実用的でない場合によく使用されます。人工骨は自家骨移植片や同種骨移植片と比較して、ドナー部位の罹患率を低減し、疾病伝播のリスクを排除し、スケーラブルに利用可能であるため、特に大量の医療システムや緊急手術環境において価値があります。

人工骨は、精密さ、オッセオインテグレーション、審美性が重視される顎顔面外科、頭蓋欠損修復、歯科インプラントなどの再建用途に使用されています。解剖学的な適合性を高め、手術時間を短縮し、術後の機能性を向上させるために、3Dプリントやカスタム形状の骨補填材がますます使用されるようになっています。手術手技が進歩し、患者の期待が高まるにつれ、人工骨ソリューションは、受動的な充填材から、現代の筋骨格ケアの能動的な生体統合コンポーネントへと進化しています。

材料革新、生物学的統合、および積層造形は、どのように製品能力を変革しているのか？

材料科学は人工骨の進化の中核をなしています。ハイドロキシアパタイトやリン酸三カルシウムといった従来のリン酸カルシウム系材料は、その生体適合性と骨伝導性が評価されています。しかし、生体活性ガラス、ポリマーセラミックハイブリッド、ナノ構造足場などの新しい複合材料は、強化された機械的強度、制御された吸収速度、優れた生物学的相互作用を提供しています。このような技術革新により、人工骨は、耐荷重用途にも非耐荷重用途にも、より適応しやすくなっています。

生物学的統合は進歩の鍵となる分野であり、人工骨製品には成長因子、幹細胞、そして骨誘導と血管新生を促進するための表面改質が組み込まれています。遺伝子組換え骨形態形成タンパク質（rhBMP）や多血小板血漿（PRP）コーティングを特徴とする製品は、特に複雑な欠損や治癒しない欠損において、骨再生を促進しています。表面テクスチャリングやナノパターニングもまた、細胞接着を改善し、宿主組織との統合を促進することで、インプラントをより生理学的に応答性の高いものにしています。

積層造形（3Dプリンティング）は、患者固有の人工骨インプラントの製造に革命をもたらしています。CTやMRIの画像データを使用することで、外科医やエンジニアは、個々の骨構造に適合する解剖学的に正確なモデルを設計し、術中の調整を最小限に抑え、生体力学的適合性を最大限に高めることができます。チタン、PEEK、またはバイオセラミック材料から製造されるこれらのカスタマイズ・インプラントは、頭蓋、脊椎、および整形外科腫瘍学手術で採用されています。製造コストが低下し、規制経路が合理化されるにつれて、3Dプリント骨代替物は個別化された整形外科治療の標準的手法になると予想されます。

人工骨ソリューションの採用を促進している臨床セグメントと地域市場は？

整形外科は、特に脊椎固定術、骨折修復術、関節再置換術において、依然として人工骨の最大の臨床セグメントです。世界の高齢化と骨粗鬆症に関連した骨折率の上昇により、ヘルスケアシステムは入院期間を短縮し、早期回復を促進する低侵襲ソリューションを優先しています。脊椎や外傷の外科手術では、人工骨が金属製固定器具とともに一般的に使用され、癒合率を高め、構造的完全性を安定させています。

歯科・顎顔面外科もまた、歯周病治療、インプラント固定、抜歯後のソケット保存における骨移植代替物の需要に牽引され、高成長を遂げている分野です。歯科の専門家は、その無菌性、扱いやすさ、一貫した吸収プロファイルにより、合成骨充填材の採用を増やしています。腫瘍学分野では、四肢温存術や腫瘍切除後の再建術、特に従来の移植片の選択肢が限られている小児や老年患者に使用されています。

地域別では、北米と欧州が先進的な手術インフラ、強力な償還制度、生物学的移植片および3Dプリント移植片技術の早期採用により市場をリードしています。アジア太平洋は、医療アクセスの拡大、医療ツーリズム、中国、インド、日本、韓国における整形外科手術件数の増加に支えられ、急速な成長を遂げています。ラテンアメリカと中東は新興市場であり、官民パートナーシップと整形外科アウトリーチ・プログラムが、外傷と再建医療における費用対効果の高い合成グラフト代替品の採用を促進しています。

規制の進化、臨床的エビデンス、コストパフォーマンスの指標は、競合戦略にどのような影響を与えているか？

FDAやEMAのような規制機関は、人工骨製品の安全性、有効性、品質管理を確保するためのガイドラインを継続的に更新しています。エビデンスに基づく承認へのシフトは、多様な患者集団における性能を検証するための長期臨床試験と市販後サーベイランスへの投資をメーカーに促しています。生物学的に強化された移植片や個別化されたインプラントに関する規制の明確化も、新しいソリューションに対する臨床医や患者の信頼を確保しつつ、技術革新を合理化しています。

コスト・パフォーマンスの最適化は、依然として採用の重要な決定要因です。病院や調達機関は、扱いやすさ、統合スピード、手術結果、自家移植片や同種移植片との比較価格などに基づいて人工骨を評価しています。モジュール式移植片システム、臨床医トレーニング、転帰追跡を提供するメーカーは、特に価格に敏感なヘルスケア環境において競争力を獲得しています。バリュー・ベースのヘルスケア・モデルは、再手術率を下げ、回復を早め、総治療費を下げる製品の重要性を高めています。

機器メーカー、バイオテクノロジー企業、研究機関の間の戦略的パートナーシップは、次世代の人工骨の開発を加速させています。これらの提携は、バイオセンサー、ドラッグデリバリー機能、再生コーティングを組み込んだスマート骨インプラントの技術革新を促進しています。競争が激化する中、ブランディング、外科医のロイヤリティ・プログラム、差別化された臨床サポート・サービスが、成熟地域と新興地域の両方において市場のポジショニングの中心となってきています。

人工骨市場の成長を促進する要因は何か？

人工骨市場は、人口動態の高齢化、整形外科の技術革新、自家移植片に代わる安全で拡張可能な代替品への需要の収束により、急速に拡大しています。骨欠損、外傷、再建のニーズが世界的に高まる中、人工骨は幅広い外科的介入において、信頼性が高く、汎用性の高いソリューションを提供します。合併症を減らし、ドナー部位の罹患をなくし、回復時間を短縮するその能力は、現代の外科手術と経済的優先事項にますます合致しています。

材料、生物学的統合、および患者固有のカスタマイズにおける製品革新は、競争力学を再構築し、臨床適応を拡大しています。規制状況、外科医の受容、研究開発パイプラインへの投資は、商業化の状況を強化しています。ヘルスケア・システムが費用対効果が高く、アウトカム重視の整形外科的ソリューションを求める中、人工骨は次世代運動器治療の要として台頭してきています。

今後、人工骨技術が個別化医療、再生療法、デジタル化された手術ワークフローといかに効果的に統合されるかによって、市場の軌道は左右されるであろう。生物学的にインテリジェントで機能的に適応するインプラントへの需要が高まる中、人工骨は、人間の骨格構造を置き換えるだけでなく、積極的に再生・修復するスマートな足場へと進化する可能性があるのだろうか。

セグメント

材料（セラミック、複合材料、ポリマー、ハイドロキシアパタイト、その他材料）、用途（脊椎固定、歯科、頭蓋顎顔面、関節再建、外傷・四肢）、エンドユーザー（病院、専門クリニック、研究・学術機関）

調査対象企業の例（合計 37注目）

• AlloSource
• Baxter International Inc.
• Biogennix
• Biomatlante
• Bone Support AB
• Cowellmedi Co., Ltd.
• Curasan AG
• DePuy Synthes（Johnson & Johnson）
• DSM Biomedical
• Epibone
• Geistlich Pharma AG
• Graftys SA
• Kuros Biosciences AG
• LifeNet Health
• Mathys Ltd Bettlach
• Maxigen Biotech Inc.
• Medtronic plc
• NovaBone Products, LLC
• NuVasive, Inc.
• Orthofix Medical Inc.

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。当社の16,491を超えるレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• その他欧州
• アジア太平洋
• その他の地域

第4章 競合

Global Artificial Bones Market to Reach US$2.4 Billion by 2030

The global market for Artificial Bones estimated at US$1.8 Billion in the year 2024, is expected to reach US$2.4 Billion by 2030, growing at a CAGR of 5.7% over the analysis period 2024-2030. Ceramics Material, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$835.7 Million by the end of the analysis period. Growth in the Composite Material segment is estimated at 7.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$461.0 Million While China is Forecast to Grow at 5.6% CAGR

The Artificial Bones market in the U.S. is estimated at US$461.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$393.1 Million by the year 2030 trailing a CAGR of 5.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.9% and 5.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Global Artificial Bones Market - Key Trends & Drivers Summarized

Why Are Artificial Bones Becoming Integral to Orthopedic, Trauma, and Reconstructive Surgical Advancements?

Artificial bones are synthetic or biologically engineered substitutes designed to replace, repair, or augment damaged or missing bone tissue. They are increasingly vital across orthopedic surgery, trauma care, dental reconstruction, and oncology-related bone defect treatments. As the global incidence of bone-related disorders rises-driven by aging populations, high-impact injuries, and chronic conditions such as osteoporosis and osteoarthritis-demand for reliable, biocompatible bone substitutes continues to surge.

In trauma and orthopedic procedures, artificial bones serve as scaffolds to promote bone regeneration, fill structural voids, and restore biomechanical integrity. These substitutes are often used in spinal fusion, long bone fracture repair, joint reconstruction, and complex revision surgeries where natural bone grafts may be insufficient or impractical. Compared to autografts or allografts, artificial bones reduce donor site morbidity, eliminate disease transmission risk, and offer scalable availability-making them particularly valuable in high-volume healthcare systems and emergency surgical environments.

In reconstructive applications, artificial bones are employed in maxillofacial surgery, cranial defect repairs, and dental implants, where precision, osseointegration, and aesthetic outcomes are paramount. 3D-printed and custom-shaped bone substitutes are increasingly being used to enhance anatomical fit, reduce surgical time, and improve post-operative functionality. As surgical techniques advance and patient expectations rise, artificial bone solutions are evolving from passive fillers to active bio-integrative components of modern musculoskeletal care.

How Are Material Innovations, Biologic Integration, and Additive Manufacturing Transforming Product Capabilities?

Material science is at the core of artificial bone evolution. Traditional calcium phosphate-based materials-such as hydroxyapatite and tricalcium phosphate-are valued for their biocompatibility and osteoconductivity. However, newer composite materials, including bioactive glass, polymer-ceramic hybrids, and nanostructured scaffolds, are offering enhanced mechanical strength, controlled resorption rates, and superior biological interaction. These innovations are making artificial bones more adaptable across load-bearing and non-load-bearing applications.

Biologic integration is a key area of advancement, with artificial bone products now incorporating growth factors, stem cells, and surface modifications to enhance osteoinduction and vascularization. Products featuring recombinant bone morphogenetic proteins (rhBMPs) or platelet-rich plasma (PRP) coatings are accelerating bone regeneration, particularly in complex or non-healing defects. Surface texturing and nano-patterning are also improving cell adhesion and promoting faster host tissue integration, making the implants more physiologically responsive.

Additive manufacturing (3D printing) is revolutionizing the production of patient-specific artificial bone implants. Using CT or MRI imaging data, surgeons and engineers can design anatomically precise models that conform to individual bone structures, minimizing intraoperative adjustments and maximizing biomechanical compatibility. These customized implants-manufactured from titanium, PEEK, or bioceramic materials-are being adopted in cranial, spinal, and orthopedic oncology surgeries. As production costs decrease and regulatory pathways streamline, 3D-printed bone substitutes are expected to become standard practice in personalized orthopedic care.

Which Clinical Segments and Regional Markets Are Driving Adoption of Artificial Bone Solutions?

Orthopedic surgery remains the largest clinical segment for artificial bones, particularly in spinal fusion, fracture repair, and joint revision procedures. With an aging global population and rising rates of osteoporosis-related fractures, healthcare systems are prioritizing minimally invasive solutions that reduce hospital stay and promote faster recovery. In spine and trauma surgery, artificial bones are commonly used alongside metal fixation devices to enhance fusion rates and stabilize structural integrity.

Dental and maxillofacial surgery is another high-growth segment, driven by demand for bone graft substitutes in periodontal treatment, implant anchorage, and post-extraction socket preservation. Dental professionals are increasingly adopting synthetic bone fillers due to their sterility, ease of handling, and consistent resorption profiles. In oncology, artificial bones are used in limb-sparing procedures and post-tumor resection reconstructions, particularly for pediatric and geriatric patients where traditional graft options may be limited.

Regionally, North America and Europe lead the market due to advanced surgical infrastructure, strong reimbursement frameworks, and early adoption of biologic and 3D-printed graft technologies. Asia-Pacific is experiencing rapid growth, supported by expanding healthcare access, medical tourism, and a rising volume of orthopedic procedures in China, India, Japan, and South Korea. Latin America and the Middle East are emerging markets where public-private partnerships and orthopedic outreach programs are driving the adoption of cost-effective synthetic graft alternatives across trauma and reconstructive care.

How Are Regulatory Evolution, Clinical Evidence, and Cost-Performance Metrics Influencing Competitive Strategy?

Regulatory bodies such as the FDA and EMA are continuously updating guidelines to ensure safety, efficacy, and quality control for artificial bone products. The shift toward evidence-based approvals is prompting manufacturers to invest in long-term clinical trials and post-market surveillance to validate performance in diverse patient populations. Regulatory clarity around biologically enhanced grafts and personalized implants is also streamlining innovation while ensuring clinician and patient confidence in new solutions.

Cost-performance optimization remains a key determinant of adoption. Hospitals and procurement agencies are evaluating artificial bones based on handling ease, integration speed, surgical outcomes, and comparative pricing versus autografts and allografts. Manufacturers that offer modular graft systems, clinician training, and outcome tracking are gaining a competitive edge, especially in price-sensitive healthcare settings. Value-based healthcare models are amplifying the importance of products that reduce revision rates, accelerate recovery, and lower total care costs.

Strategic partnerships among device manufacturers, biotech firms, and research institutions are accelerating the development of next-generation artificial bones. These collaborations are fostering innovation in smart bone implants that incorporate biosensors, drug-delivery functions, or regenerative coatings. With competition intensifying, branding, surgeon loyalty programs, and differentiated clinical support services are becoming central to market positioning across both mature and emerging regions.

What Are the Factors Driving Growth in the Artificial Bones Market?

The artificial bones market is expanding rapidly, driven by the convergence of aging demographics, orthopedic innovation, and demand for safe, scalable alternatives to autologous grafts. As the global burden of bone defects, trauma injuries, and reconstructive needs grows, artificial bones offer a reliable, versatile solution across a wide range of surgical interventions. Their ability to reduce complications, eliminate donor-site morbidity, and shorten recovery times is increasingly aligned with modern surgical and economic priorities.

Product innovation in materials, biologic integration, and patient-specific customization is reshaping competitive dynamics and expanding clinical indications. Regulatory backing, surgeon acceptance, and investment in R&D pipelines are strengthening the commercialization landscape. As healthcare systems seek cost-effective, outcomes-driven orthopedic solutions, artificial bones are emerging as a cornerstone of next-generation musculoskeletal treatment.

Looking ahead, the market’s trajectory will depend on how effectively artificial bone technologies integrate with personalized medicine, regenerative therapies, and digitized surgical workflows. As demand for biologically intelligent and functionally adaptive implants rises, could artificial bones evolve into smart scaffolds that not only replace but actively regenerate and restore human skeletal structures?

SCOPE OF STUDY:

The report analyzes the Artificial Bones market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Material (Ceramics, Composite, Polymer, Hydroxyapatite, Other Materials); Application (Spinal Fusion, Dental, Craniomaxillofacial, Joint Reconstruction, Trauma & Extremities); End-User (Hospitals, Specialty Clinics, Research & Academic Institutes)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 37 Featured) -

• AlloSource
• Baxter International Inc.
• Biogennix
• Biomatlante
• Bone Support AB
• Cowellmedi Co., Ltd.
• Curasan AG
• DePuy Synthes (Johnson & Johnson)
• DSM Biomedical
• Epibone
• Geistlich Pharma AG
• Graftys SA
• Kuros Biosciences AG
• LifeNet Health
• Mathys Ltd Bettlach
• Maxigen Biotech Inc.
• Medtronic plc
• NovaBone Products, LLC
• NuVasive, Inc.
• Orthofix Medical Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Artificial Bones - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Trauma, Fractures, and Orthopedic Disorders Throws the Spotlight on Artificial Bone Implants
  • Growth in Minimally Invasive and Reconstructive Surgeries Spurs Demand for Biocompatible Bone Substitutes
  • OEM Advancements in 3D Printing and Scaffold Engineering Strengthen Customization of Synthetic Bone Designs
  • Increased Use of Calcium Phosphate and Hydroxyapatite Compounds Enhances Integration With Natural Bone
  • Adoption in Dental Implants and Craniofacial Surgery Expands Scope Beyond Large Orthopedic Reconstructions
  • Surge in Geriatric Population and Osteoporosis Cases Drives Market for Bone Void Fillers
  • Expansion of Bioactive and Growth Factor-Infused Materials Bodes Well for Accelerated Regeneration
  • Use of Artificial Bones in Trauma Management and Military Medicine Enhances Emergency Response Capabilities
  • Growth in Veterinary Orthopedic Procedures Opens Parallel Demand in Animal Healthcare
  • Global Investment in Biomaterials R&D Supports Innovation in Hybrid and Smart Bone Graft Solutions
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Artificial Bones Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Bones by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World 6-Year Perspective for Artificial Bones by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Ceramics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 5: World 6-Year Perspective for Ceramics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 6: World Recent Past, Current & Future Analysis for Composite by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 7: World 6-Year Perspective for Composite by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World 6-Year Perspective for Polymer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Hydroxyapatite by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 11: World 6-Year Perspective for Hydroxyapatite by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 12: World Recent Past, Current & Future Analysis for Other Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 13: World 6-Year Perspective for Other Materials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Trauma & Extremities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World 6-Year Perspective for Trauma & Extremities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Spinal Fusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 17: World 6-Year Perspective for Spinal Fusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 18: World Recent Past, Current & Future Analysis for Dental by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 19: World 6-Year Perspective for Dental by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Craniomaxillofacial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World 6-Year Perspective for Craniomaxillofacial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 22: World Recent Past, Current & Future Analysis for Joint Reconstruction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 23: World 6-Year Perspective for Joint Reconstruction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 24: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 25: World 6-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World 6-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 28: World Recent Past, Current & Future Analysis for Research & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 29: World 6-Year Perspective for Research & Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Artificial Bones Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 30: USA Recent Past, Current & Future Analysis for Artificial Bones by Material - Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 31: USA 6-Year Perspective for Artificial Bones by Material - Percentage Breakdown of Value Sales for Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials for the Years 2025 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Artificial Bones by Application - Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA 6-Year Perspective for Artificial Bones by Application - Percentage Breakdown of Value Sales for Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction for the Years 2025 & 2030
  • TABLE 34: USA Recent Past, Current & Future Analysis for Artificial Bones by End-user - Hospitals, Specialty Clinics and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 35: USA 6-Year Perspective for Artificial Bones by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Research & Academic Institutes for the Years 2025 & 2030
• CANADA
  • TABLE 36: Canada Recent Past, Current & Future Analysis for Artificial Bones by Material - Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 37: Canada 6-Year Perspective for Artificial Bones by Material - Percentage Breakdown of Value Sales for Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials for the Years 2025 & 2030
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Artificial Bones by Application - Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Canada 6-Year Perspective for Artificial Bones by Application - Percentage Breakdown of Value Sales for Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction for the Years 2025 & 2030
  • TABLE 40: Canada Recent Past, Current & Future Analysis for Artificial Bones by End-user - Hospitals, Specialty Clinics and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 41: Canada 6-Year Perspective for Artificial Bones by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Research & Academic Institutes for the Years 2025 & 2030
• JAPAN
  • Artificial Bones Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 42: Japan Recent Past, Current & Future Analysis for Artificial Bones by Material - Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 43: Japan 6-Year Perspective for Artificial Bones by Material - Percentage Breakdown of Value Sales for Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials for the Years 2025 & 2030
  • TABLE 44: Japan Recent Past, Current & Future Analysis for Artificial Bones by Application - Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Japan 6-Year Perspective for Artificial Bones by Application - Percentage Breakdown of Value Sales for Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction for the Years 2025 & 2030
  • TABLE 46: Japan Recent Past, Current & Future Analysis for Artificial Bones by End-user - Hospitals, Specialty Clinics and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 47: Japan 6-Year Perspective for Artificial Bones by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Research & Academic Institutes for the Years 2025 & 2030
• CHINA
  • Artificial Bones Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 48: China Recent Past, Current & Future Analysis for Artificial Bones by Material - Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 49: China 6-Year Perspective for Artificial Bones by Material - Percentage Breakdown of Value Sales for Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials for the Years 2025 & 2030
  • TABLE 50: China Recent Past, Current & Future Analysis for Artificial Bones by Application - Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: China 6-Year Perspective for Artificial Bones by Application - Percentage Breakdown of Value Sales for Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction for the Years 2025 & 2030
  • TABLE 52: China Recent Past, Current & Future Analysis for Artificial Bones by End-user - Hospitals, Specialty Clinics and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 53: China 6-Year Perspective for Artificial Bones by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Research & Academic Institutes for the Years 2025 & 2030
• EUROPE
  • Artificial Bones Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 54: Europe Recent Past, Current & Future Analysis for Artificial Bones by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 55: Europe 6-Year Perspective for Artificial Bones by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
  • TABLE 56: Europe Recent Past, Current & Future Analysis for Artificial Bones by Material - Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Europe 6-Year Perspective for Artificial Bones by Material - Percentage Breakdown of Value Sales for Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials for the Years 2025 & 2030
  • TABLE 58: Europe Recent Past, Current & Future Analysis for Artificial Bones by Application - Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 59: Europe 6-Year Perspective for Artificial Bones by Application - Percentage Breakdown of Value Sales for Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction for the Years 2025 & 2030
  • TABLE 60: Europe Recent Past, Current & Future Analysis for Artificial Bones by End-user - Hospitals, Specialty Clinics and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 61: Europe 6-Year Perspective for Artificial Bones by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Research & Academic Institutes for the Years 2025 & 2030
• FRANCE
  • Artificial Bones Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 62: France Recent Past, Current & Future Analysis for Artificial Bones by Material - Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: France 6-Year Perspective for Artificial Bones by Material - Percentage Breakdown of Value Sales for Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials for the Years 2025 & 2030
  • TABLE 64: France Recent Past, Current & Future Analysis for Artificial Bones by Application - Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 65: France 6-Year Perspective for Artificial Bones by Application - Percentage Breakdown of Value Sales for Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction for the Years 2025 & 2030
  • TABLE 66: France Recent Past, Current & Future Analysis for Artificial Bones by End-user - Hospitals, Specialty Clinics and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 67: France 6-Year Perspective for Artificial Bones by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Research & Academic Institutes for the Years 2025 & 2030
• GERMANY
  • Artificial Bones Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 68: Germany Recent Past, Current & Future Analysis for Artificial Bones by Material - Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Germany 6-Year Perspective for Artificial Bones by Material - Percentage Breakdown of Value Sales for Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials for the Years 2025 & 2030
  • TABLE 70: Germany Recent Past, Current & Future Analysis for Artificial Bones by Application - Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 71: Germany 6-Year Perspective for Artificial Bones by Application - Percentage Breakdown of Value Sales for Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction for the Years 2025 & 2030
  • TABLE 72: Germany Recent Past, Current & Future Analysis for Artificial Bones by End-user - Hospitals, Specialty Clinics and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 73: Germany 6-Year Perspective for Artificial Bones by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Research & Academic Institutes for the Years 2025 & 2030
• ITALY
  • TABLE 74: Italy Recent Past, Current & Future Analysis for Artificial Bones by Material - Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Italy 6-Year Perspective for Artificial Bones by Material - Percentage Breakdown of Value Sales for Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials for the Years 2025 & 2030
  • TABLE 76: Italy Recent Past, Current & Future Analysis for Artificial Bones by Application - Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 77: Italy 6-Year Perspective for Artificial Bones by Application - Percentage Breakdown of Value Sales for Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction for the Years 2025 & 2030
  • TABLE 78: Italy Recent Past, Current & Future Analysis for Artificial Bones by End-user - Hospitals, Specialty Clinics and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 79: Italy 6-Year Perspective for Artificial Bones by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Research & Academic Institutes for the Years 2025 & 2030
• UNITED KINGDOM
  • Artificial Bones Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 80: UK Recent Past, Current & Future Analysis for Artificial Bones by Material - Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: UK 6-Year Perspective for Artificial Bones by Material - Percentage Breakdown of Value Sales for Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials for the Years 2025 & 2030
  • TABLE 82: UK Recent Past, Current & Future Analysis for Artificial Bones by Application - Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 83: UK 6-Year Perspective for Artificial Bones by Application - Percentage Breakdown of Value Sales for Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction for the Years 2025 & 2030
  • TABLE 84: UK Recent Past, Current & Future Analysis for Artificial Bones by End-user - Hospitals, Specialty Clinics and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 85: UK 6-Year Perspective for Artificial Bones by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Research & Academic Institutes for the Years 2025 & 2030
• REST OF EUROPE
  • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Artificial Bones by Material - Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Rest of Europe 6-Year Perspective for Artificial Bones by Material - Percentage Breakdown of Value Sales for Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials for the Years 2025 & 2030
  • TABLE 88: Rest of Europe Recent Past, Current & Future Analysis for Artificial Bones by Application - Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 89: Rest of Europe 6-Year Perspective for Artificial Bones by Application - Percentage Breakdown of Value Sales for Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction for the Years 2025 & 2030
  • TABLE 90: Rest of Europe Recent Past, Current & Future Analysis for Artificial Bones by End-user - Hospitals, Specialty Clinics and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 91: Rest of Europe 6-Year Perspective for Artificial Bones by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Research & Academic Institutes for the Years 2025 & 2030
• ASIA-PACIFIC
  • Artificial Bones Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Bones by Material - Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Asia-Pacific 6-Year Perspective for Artificial Bones by Material - Percentage Breakdown of Value Sales for Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials for the Years 2025 & 2030
  • TABLE 94: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Bones by Application - Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 95: Asia-Pacific 6-Year Perspective for Artificial Bones by Application - Percentage Breakdown of Value Sales for Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction for the Years 2025 & 2030
  • TABLE 96: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Bones by End-user - Hospitals, Specialty Clinics and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 97: Asia-Pacific 6-Year Perspective for Artificial Bones by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Research & Academic Institutes for the Years 2025 & 2030
• REST OF WORLD
  • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Artificial Bones by Material - Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Rest of World 6-Year Perspective for Artificial Bones by Material - Percentage Breakdown of Value Sales for Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials for the Years 2025 & 2030
  • TABLE 100: Rest of World Recent Past, Current & Future Analysis for Artificial Bones by Application - Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 101: Rest of World 6-Year Perspective for Artificial Bones by Application - Percentage Breakdown of Value Sales for Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction for the Years 2025 & 2030
  • TABLE 102: Rest of World Recent Past, Current & Future Analysis for Artificial Bones by End-user - Hospitals, Specialty Clinics and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 103: Rest of World 6-Year Perspective for Artificial Bones by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Research & Academic Institutes for the Years 2025 & 2030

IV. COMPETITION